Ep. 1270: Where it's like comparing apples and googles
With Google I/O 2013 underway, we chat with Jill Schlesinger about the company's $900 stock price. Also on the docket is college loans, Sony's fragmentation, hockey and more.
Recommended Stories
BusinessYahoo FinanceThe FDIC change that leaves wealthy bank depositors with less protection
Affluent Americans may want to double-check how much of their bank deposits are protected by government-backed insurance. The rules governing trust accounts just changed.
- SportsYahoo Sports
Former NBA guard Darius Morris dies at 33
Former NBA guard Darius Morris has died at the age of 33. He played for five teams during his four NBA seasons. Morris played college basketball at Michigan.
- SportsYahoo Sports
Kyle Larson beats Chris Buescher at Kansas in closest finish in NASCAR history
Larson won by 0.001 seconds.
- SportsYahoo Sports
No one was airing Angel Reese and Kamilla Cardoso's WNBA preseason debuts, so an X user livestreamed it
The quality was choppy, but it was better than what the WNBA had.
- SportsYahoo Sports
2024 NFL Draft grades: Denver Broncos earn one of our lowest grades mostly due to one pick
Yahoo Sports' Charles McDonald breaks down the Broncos' 2024 draft.
- U.S.Yahoo Sports
New details emerge in alleged gambling ring behind Shohei Ohtani-Ippei Mizuhara scandal
It turns out the money was going from Ohtani's bank account to an illegal bookie to ... casinos.
- SportsYahoo Sports
Bulls' Lonzo Ball picks up $21.4 million option for 2024-25 season amid knee concerns
Ball hasn't played since the 2021-22 season.
- SportsYahoo Sports
NFL Power Rankings, draft edition: Did Patriots fix their offensive issues?
Which teams did the best in the NFL Draft?
- SportsYahoo Sports
Formula 1: Miami Grand Prix sends cease and desist letter to prevent Donald Trump fundraiser during race
Race organizers say they'll revoke a Trump fundraiser's suite license if he holds an event for the former president on Sunday at the race.
- BusinessYahoo Finance
CVS stock plunges after earnings numbers one analyst 'did not even believe'
CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.